Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
RESEARCH TOOLSreports
Holding ADAP?
Track your performance easily
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 128.23M | $ 5.68M | $ 231.00K | $ 7.32M | $ 5.13M |
| Gross Profit | $ 128.23M | $ 5.68M | $ 231.00K | $ 7.32M | $ 5.13M |
| EBIT | $ 70.05M | $ -47.98M | $ -49.86M | $ -46.63M | $ -20.71M |
| EBITDA | $ 72.77M | $ -45.17M | $ -46.98M | $ -43.74M | $ -19.22M |
| Net Income Common Stockholders | $ 69.52M | $ -48.50M | $ -47.92M | $ -45.60M | $ -21.39M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 214.79M | $ 143.65M | $ 146.94M | $ 161.73M | $ 204.71M |
| Total Assets | $ 321.70M | $ 258.01M | $ 282.62M | $ 296.64M | $ 342.98M |
| Total Debt | $ 47.35M | $ 23.69M | $ 25.23M | $ 25.60M | $ 26.34M |
| Net Debt | $ -167.44M | $ -119.96M | $ -121.70M | $ -136.13M | $ -178.37M |
| Total Liabilities | $ 225.43M | $ 233.63M | $ 243.10M | $ 208.51M | $ 216.33M |
| Stockholders Equity | $ 96.27M | $ 24.38M | $ 39.51M | $ 88.13M | $ 126.65M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 46.66M | $ -32.31M | $ -15.50M | $ -45.45M | $ -44.47M |
| Operating Cash Flow | $ 47.40M | $ -31.95M | $ -14.68M | $ -45.16M | $ -43.76M |
| Investing Cash Flow | $ -743.00K | $ -358.00K | $ 68.20M | $ 57.31M | $ 2.69M |
| Financing Cash Flow | $ 24.51M | $ 29.23M | $ 74.00K | $ 596.00K | $ 14.00K |